Targeting the androgen receptor in triple-negative breast cancer: current perspectives

od Mina, Alain, Yoder, Rachel, Sharma, Priyanka
izdano v Onco Targets Ther (2017)

Racial/Ethnic differences in the prevalence of anxiety using the Vanderbilt ADHD scale in a diverse community outpatient setting

od Bauer, Nerissa S., Yoder, Rachel, Carroll, Aaron E., Downs, Stephen M.
izdano v J Dev Behav Pediatr (2016)

Clinical and biomarker results from phase I/II study of PI3K inhibitor alpelisib plus nab-paclitaxel in HER2-negative metastatic breast cancer

od Sharma, Priyanka, Abramson, Vandana G., O’Dea, Anne, Nye, Lauren, Mayer, Ingrid, Pathak, Harsh B., Hoffmann, Marc, Stecklein, Shane R., Elia, Manana, Lewis, Sharon, Scott, Jecinta, De Jong, Jilliann A., Wang, Yen Y., Yoder, Rachel, Schwensen, Kelsey, Finke, Karissa, Heldstab, Jaimie, LaFaver, Stephanie, Williamson, Stephen K., Phadnis, Milind, Reed, Gregory A., Kimler, Bruce F., Khan, Qamar J., Godwin, Andrew K.
izdano v Clin Cancer Res (2021)

Randomized phase II trial of anthracycline-free and anthracycline-containing neoadjuvant carboplatin chemotherapy regimens in stage I-III triple-negative breast cancer (NeoSTOP)

od Sharma, Priyanka, Kimler, Bruce F., O’Dea, Anne, Nye, Lauren, Wang, Yen Y., Yoder, Rachel, Staley, Joshua M., Prochaska, Lindsey, Wagner, Jamie, Amin, Amanda L., Larson, Kelsey, Balanoff, Christa, Elia, Manana, Crane, Gregory, Madhusudhana, Sheshadri, Hoffmann, Marc, Sheehan, Maureen, Rodriguez, Roberto, Finke, Karissa, Shah, Rajvi, Satelli, Deepti, Shrestha, Anuj, Beck, Larry, McKittrick, Richard, Pluenneke, Robert, Raja, Vinay, Beeki, Venkatadri, Corum, Larry, Heldstab, Jaimie, LaFaver, Stephanie, Prager, Micki, Phadnis, Milind, Mudaranthakam, Dinesh Pal, Jensen, Roy A., Godwin, Andrew K., Salgado, Roberto, Mehta, Kathan, Khan, Qamar
izdano v Clin Cancer Res (2020)